AnaptysBio (ANAB) Financials

$56.80

$-0.66 (-1.15%)

As on 04-Sep-2026 16:00EDT

Market cap

$1,682 Mln

Revenue (TTM)

$232 Mln

P/E Ratio

--

P/B Ratio

129.8

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Operating Revenue	232.39	234.60	91.28	17.16	10.29	63.18
Cost of Revenue	-38.15	2.42	163.84	132.28	88.80	98.50
Gross Profit	270.54	232.18	-72.56	-115.13	-78.51	-35.32
Operating Expenses	229.74	184.28	42.39	49.29	36.64	21.49
Operating Profit (EBIT)	40.80	47.90	-114.95	-164.41	-115.15	-56.81
Other Income	--	--	--	--	-18.37	-1.40
Profit before Tax	-26.63	-13.07	-145.23	-163.62	-128.70	-57.80
Provision for Tax	0.16	0.16	0.00	0.00	0.02	-0.60
Profit after Tax (Net Income)	-26.79	-13.23	-145.23	-163.62	-128.72	-57.80
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	--	-128.72	-57.80

Liabilities ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Shareholder's Funds	12.75	37.21	70.87	88.10	262.10	356.43
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	275.24	288.56	367.54	326.84	322.23	270.54
Current Liabilities	41.70	38.63	45.43	37.44	26.05	16.10
Total Liabilities	371.39	364.40	483.83	452.39	610.38	643.07

Assets ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Non-Current Assets	13.58	14.15	51.96	45.55	163.18	89.19
Current Assets	316.11	350.25	431.88	406.84	447.21	553.88
Total Assets	371.39	364.40	483.83	452.39	610.38	643.07
Total Debt*	277.36	14.11	369.46	17.81	19.45	20.96
Net Current Assets	274.41	311.63	386.45	369.39	421.15	537.78

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Cash From Operating Activities	--	19.70	-135.34	-120.80	-73.59	-45.92
Cash Flow from Investing Activities	--	228.03	95.40	144.75	-394.85	38.84
Cash from Financing Activities	--	-132.61	127.05	-59.30	44.02	252.30
Net Cash Inflow / Outflow	--	--	--	--	-424.42	245.21

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Adjusted EPS ($)	-1.08	-0.42	-4.77	-6.15	-4.53	-2.10
Cash EPS ($)	--	-0.34	-4.69	-6.06	-4.44	-2.02
Adjusted Book Value ($)	--	1.19	2.33	3.31	9.21	12.95
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	0.63	-4.44	-4.54	-2.59	-1.67
Free Cash Flow per Share ($)	--	0.63	-4.46	-4.57	-2.60	-1.72

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
ROCE (%)	--	-5.38	-53.17	-84.46	-39.07	-14.93
ROE (%)	--	-24.49	-182.71	-93.44	-41.62	-15.35
ROA (%)	-6.40	-3.12	-31.02	-30.79	-20.54	-10.91
EBIT Margin (%)	24.13	28.48	-104.23	-915.50	-1,045.90	-91.49
Net Margin (%)	-11.53	-5.64	-159.10	-953.66	1,592.53	-93.56
Cash Profit Margin (%)	0.00	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Revenue Growth (%)	107.73	1.57	4.32	0.67	-0.84	-0.16
EBIT Growth (%)	171.18	170.24	39.43	-45.99	-86.16	-189.98
Net Profit Growth (%)	80.95	90.89	11.24	-27.11	-122.72	-189.98
EPS Growth (%)	77.69	0.91	0.22	-0.36	-1.16	-1.94
Book Value Growth (%)	-59.98	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Price / Earnings	--	-114.84	-2.78	-3.48	-6.85	-16.55
Price / Book Value	129.80	40.84	5.69	6.46	3.36	2.68
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	23.62	17.65	-4.18	-1.26	-4.37	-7.71
Close Price ($)	36.97	32.32	8.83	14.28	20.66	23.17
High Price ($)	45.59	34.98	27.54	21.17	24.04	25.26
Low Price ($)	10.27	8.14	8.34	8.91	12.13	11.81
Market Cap ($ Cr)	1,681.76	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debt to Equity	--	0.38	5.21	0.20	0.07	0.06
Short term debt to equity ratio	0.17	0.06	0.03	0.02	0.01	0.00
Current Ratio	7.58	9.07	9.51	10.87	17.16	34.40
Quick Ratio	7.58	--	--	10.87	17.16	34.40
Interest Coverage	0.68	0.84	-1.90	-8.69	-5.10	-39.86

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debtors to sales (%)	11.08	14.43	44.66	39.93	13.79	1.39
Asset Turnover	0.55	0.55	0.19	0.03	0.02	0.12
Receivable days	--	58.08	95.27	88.03	40.74	2.53
Inventory Days	--	--	0.00	0.00	0.00	0.00
Payable days	--	593.40	9.70	10.33	9.31	11.05
Cash Conversion Cycle	--	--	85.57	77.70	31.44	-8.51

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.